Moreover, the SIRT2‐24a co‐crystal structure enabled the structure‐based campaign that led to compound 25a which shows great potency and selectivity against SIRT2 and exhibits anticancer activity in breast cancer cells.370. The gene discussed is SIRT2; the disease is breast cancer.